✦ LIBER ✦

Prophylaxis of cytomegalovirus disease in high-risk patients

✍ Scribed by M. Scholz; J. Cinatl; H. W. Doerr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Valganciclovir prophylaxis in patients a

✍ D.J. Taber; E. Ashcraft; G.M. Baillie; S. Berkman; J. Rogers; P.K. Baliga; P.R. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

PUK16 COST-EFFECTIVENESS OF VALGANCICLOV

✍ C. Vicente; A. Humar; C. Lemieux; R. Zilbershtein; P. Douglas; L. Formica; C. Pi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Failure of Ganciclovir Prophylaxis of Pr

✍ D.J. Conti; A. Isenberg; G.K. Shen; A. Hahn; T.P. Singh 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Cytomegalovirus Disease in High-Risk Tra

✍ Enver Akalin; Vinita Sehgal; Scott Ames; Sabera Hossain; Lisa Daly; Murphy Barba 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Prophylaxis versus preemptive therapy fo

✍ Marta Bodro; Núria Sabé; Laura Lladó; Carme Baliellas; Jordi Niubó; Jose Castell 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Gancyclovir Prophylaxis in High Risk Pat

✍ A. Campino 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB